UTokyo Innovation Platform Company

Logomix is a pioneering synthetic biology company. With its unprecedented genome engineering platform, Geno-Writing™, Logomix facilitates precise and Mb-scale manipulation of genomic sequences within human cells, leads the development of super-functionalized hypoimmune cells to address critical limitations in contemporary cell therapy approaches, and unlocks the potential with a TAM of solid tumors and 70,000 genetic diseases worth trillion of dollars.

Modulus Discovery is a private Tokyo-based preclinical stage drug discovery company focused on rapid design and generation of small molecule clinical candidates for a range of high-value disease targets through the use of its cutting-edge computational drug discovery expertise and unique biology insights. The international team at Modulus is comprised of drug design and disease biology experts with previous R&D experience at global pharmaceutical, biotechnology , and computational technology firms.

TagCyx’s scientific team has established its proprietary Xenoligo® technology platform, allowing high functional oligonucletide drug discovery. The Xenoligo® platform utilizes genetic alphabet expansion by unnatural base-pairs to generate customized nucleic acid suited for therapeutic applications.

Telexistence aims to be the systematic innovator of scale in robotics. Innovator means new stuff. And scale means big, systematic ways of looking at things done in a way that’s reproducible.

Heartseed has set a mission to “open the door to heart disease treatment with regenerative medicine” and is working toward the day-to-day clinical application of myocardial regenerative medicine.

LiberoThera provides drug discovery research and development services. It focuses on making drugs with GPCRs for membrane proteins. LiberoThera was founded in 2018 and is located in Tokyo.

Sonas Inc., based in Tokyo, Japan, specializes in the planning, design, manufacturing, and sales of hardware and software solutions for sensing and measurement. The company is developing "UNISONet," an innovative wireless communication technology aimed at addressing traditional Internet of Things (IoT) challenges. This technology distinguishes itself by employing a unique approach that integrates features such as power-saving capabilities, high-speed acquisition, low-latency bidirectional communication, and advanced data collection methods. These advancements enable the effective sensing of both small variables like temperature and humidity, as well as larger data sets including acceleration and images. By focusing on high-quality wireless sensing, Sonas aims to establish itself as a fundamental component of modern society.

ARAV offers solutions for construction site problems updating the site. The company works to ensure on-site safety and reduce risks as soon as possible around the world. Control construction equipment remotely via the internet. Compatible with smartphones, tablets, digging, cutting, and putting to the truck, and person detection.

RIN Institute is a bio-venture firm dedicated to the research and development of antibody-based medicines and external diagnostic drugs.

HarvestX is a company that specializes in robotic technology for agriculture, emerging from a project at the University of Tokyo. Initially focused on adapting robotics to farming, the company identified the potential of indoor vertical farms for fruit production through extensive discussions and trials with various stakeholders in the food industry. It has developed a unique automated pollination robot that addresses a significant challenge in fruit cultivation. This technology utilizes a depth camera and image processing algorithms to recognize flowers and fruits, facilitating effective pollination and harvesting. By providing solutions to the labor shortages in agriculture, HarvestX aims to enhance the stability of food production in controlled environments.

Urban X Technologies' service supports inspection of the road conditions. AI technology-based inspection enables to detect the damage of the road and send an alert to investigator. This gives more efficient way of inspection rather than relying on visual confirmation by an investigator for any damages on the road.

BionicM is a Tokyo-based company focused on researching, developing, and commercializing advanced mobility devices that integrate robotics with the human body. Established as a joint-stock company in 2018, BionicM specializes in high-performance robotic prosthetics, including ankle-foot and knee joints, designed to enhance mobility for individuals with disabilities. The company has been engaged in innovative technology research since 2015 at the University of Tokyo's Information Systems Engineering Laboratory, working under the guidance of Professor Inaba. BionicM's products aim to enable users, including both handicapped and non-handicapped individuals, to perform essential daily activities such as standing, walking, and climbing stairs.

Planning, research and development, designing, manufacturing and distribution of medical device and healthcare devices. Consulting service in management and strategy on technology in medical device field. Supporting research and development processes.

Onedot offers apps and platforms for the diverse need of their customers. Babily, PetNote, LadyX, and MN Consulting Room are a few of the company's apps. Babily is a parenting video platform, PetNote is an app for pet health, LadyX is a business platform for beauty and health, and MN Consulting Room is a medical platform for travelers to Japan. Onedot additionally aids in the advancement of Chinese digital business plans.

Modulus Discovery is a private Tokyo-based preclinical stage drug discovery company focused on rapid design and generation of small molecule clinical candidates for a range of high-value disease targets through the use of its cutting-edge computational drug discovery expertise and unique biology insights. The international team at Modulus is comprised of drug design and disease biology experts with previous R&D experience at global pharmaceutical, biotechnology , and computational technology firms.

TagCyx’s scientific team has established its proprietary Xenoligo® technology platform, allowing high functional oligonucletide drug discovery. The Xenoligo® platform utilizes genetic alphabet expansion by unnatural base-pairs to generate customized nucleic acid suited for therapeutic applications.

Aidemy Inc. is a Tokyo-based company that offers online artificial intelligence programming services aimed at individuals and enterprises. Founded in 2014, it provides a comprehensive learning platform where users can acquire AI technology skills through practical applications. Aidemy's services include an all-in-one teaching environment and digital transformation support, facilitating the development of digital talent in organizations. Its solutions are particularly beneficial for corporations in the manufacturing sector, as well as smaller companies and academic institutions. Aidemy's offerings range from online learning resources to consulting services that assist businesses in implementing AI and digital transformation initiatives, ensuring effective human resource development and operational support.

AccRna, Inc.'s aim is to promote therapeutic innovation in the form of nucleic acid medicine utilizing our robust DDS platform, providing effective treatment for refractory diseases for which there is currently no cure. Our dream is to deliver a “radical cure” to patients suffering from refractory diseases all over the world by safely and efficiently achieving the ultimate in the therapy utilizing nucleic acid.

WealthNavi offers a platform for asset managers which uses risk management algorithm for asset management advice.

Synspective provides SAR data and remote monitoring services to government agencies. Its satellite data technology utilizes and integrates data from satellite constellations, big data, and machine learning. It provides various satellite services, including remote sensing and satellite imagery using small-sized SAR satellites that can measure human activity over a wide area on earth, regardless of time or weather.

Connected Robotics is an information technology company that designs and manufactures robotic arms for enterprises. The company's product, OctoChef, provides cooking services. It caters to individual restaurants, shopping malls, stations, service areas, amusement centers, and large-scale events. The company was founded in 2014 and is based in Koganei-shi, Japan.

Astroscale is one of the few companies in the world proposing to aid in the removal of orbital debris through the provision of end-of-life (EOL) and active debris removal (ADR) services. In addition to providing a technical solution, Astroscale is helping to define the business case for this service and is working with national space agencies, international institutions, non-profit organizations, insurance companies, and satellite operators to develop norms, regulations, and incentives that contribute to the responsible use of space.

EdiGENE Inc. is a biotechnology company that specializes in developing therapeutics for genetic disorders. Founded in 2016 and headquartered in Tokyo, Japan, with additional offices in Cambridge, Massachusetts, the company leverages its proprietary technologies, including clustered regularly interspaced short palindromic repeats (CRISPR) and guide nucleotide directed modulation (GNDM), to create innovative treatments. EdiGENE's focus is on addressing unmet medical needs through its advanced therapeutic solutions, supported by a strong foundation of intellectual property licensed from the University of Tokyo.

CREWT Medical Systems, Inc. developed world first head-mounted perimeter, compatible standard automated perimeter, based on our cutting edge lens designing techniques and software engineering that meets the needs of the clinical site. The company name “CREWT” is an acronym for “CREation” “Weave” “Technologies“. We aims to create “new value” by weaving up the existing excellent technology in the world. We will continue to make effort to create and provide human-centric medical devices for a better Quality Of Vision. Our mission is to ‘CRE’ate new values by ‘W’eaving up existing ‘T’echnologies, acronymized as “CREWT”.

Axelspace is a startup company developing businesses in the microsatellite field. Axelspace plans to construct a monitoring platform to cover the entire globe on a daily basis at extremely low cost.

Astroscale is one of the few companies in the world proposing to aid in the removal of orbital debris through the provision of end-of-life (EOL) and active debris removal (ADR) services. In addition to providing a technical solution, Astroscale is helping to define the business case for this service and is working with national space agencies, international institutions, non-profit organizations, insurance companies, and satellite operators to develop norms, regulations, and incentives that contribute to the responsible use of space.

Synspective provides SAR data and remote monitoring services to government agencies. Its satellite data technology utilizes and integrates data from satellite constellations, big data, and machine learning. It provides various satellite services, including remote sensing and satellite imagery using small-sized SAR satellites that can measure human activity over a wide area on earth, regardless of time or weather.

Telexistence aims to be the systematic innovator of scale in robotics. Innovator means new stuff. And scale means big, systematic ways of looking at things done in a way that’s reproducible.

Braizon Therapeutics, Inc. was established with the aim of applying and implementing, within the fields of medicine and life science, innovative technology for the delivery of drugs to the brain as the outcome of collaborative research by Professor Kazunori Kataoka from the Graduate School of Engineering/Medicine, the University of Tokyo and Professor Takanori Yokota from the Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University.

TagCyx’s scientific team has established its proprietary Xenoligo® technology platform, allowing high functional oligonucletide drug discovery. The Xenoligo® platform utilizes genetic alphabet expansion by unnatural base-pairs to generate customized nucleic acid suited for therapeutic applications.

AccRna, Inc.'s aim is to promote therapeutic innovation in the form of nucleic acid medicine utilizing our robust DDS platform, providing effective treatment for refractory diseases for which there is currently no cure. Our dream is to deliver a “radical cure” to patients suffering from refractory diseases all over the world by safely and efficiently achieving the ultimate in the therapy utilizing nucleic acid.

Alivas Inc. is a medical company based in Hongo, Tokyo, Japan, that specializes in developing therapeutic medical devices aimed at treating refractory constipation. Founded in 2017, Alivas emerged as a joint venture between Stanford University and the University of Tokyo, leveraging the Japan Biodesign program to foster innovative solutions in medical device creation. The company's primary focus is on addressing intractable chronic constipation, providing patients with effective treatment options to alleviate their condition and improve their quality of life.

Xenoma, Inc. is a Tokyo-based company specializing in the development of e-skin, a platform for wearable electronic apparel that monitors various physiological functions such as motion, breathing, pressure, and body temperature. As a spin-off from the University of Tokyo's Someya Group Organic Transistor Lab, Xenoma leverages advancements in organic electronics to create ultrathin and ultraflexible devices that seamlessly integrate with the human body. Their innovative clothing line features highly sensitive motion sensors capable of tracking body movement and posture, facilitating the collection of valuable health data. This data can be used to enhance healthcare solutions by combining it with big data analytics, while their products remain comfortable, durable, and machine washable for everyday use.

CREWT Medical Systems, Inc. developed world first head-mounted perimeter, compatible standard automated perimeter, based on our cutting edge lens designing techniques and software engineering that meets the needs of the clinical site. The company name “CREWT” is an acronym for “CREation” “Weave” “Technologies“. We aims to create “new value” by weaving up the existing excellent technology in the world. We will continue to make effort to create and provide human-centric medical devices for a better Quality Of Vision. Our mission is to ‘CRE’ate new values by ‘W’eaving up existing ‘T’echnologies, acronymized as “CREWT”.